AU5685296A - Immunoassay for glucagon like protein 1 (glp-1) in plasma - Google Patents

Immunoassay for glucagon like protein 1 (glp-1) in plasma

Info

Publication number
AU5685296A
AU5685296A AU56852/96A AU5685296A AU5685296A AU 5685296 A AU5685296 A AU 5685296A AU 56852/96 A AU56852/96 A AU 56852/96A AU 5685296 A AU5685296 A AU 5685296A AU 5685296 A AU5685296 A AU 5685296A
Authority
AU
Australia
Prior art keywords
glp
glucagon
immunoassay
plasma
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56852/96A
Inventor
Lennart Andersen
Flemming Stig Larsen
David Owens
Lone Pridal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU5685296A publication Critical patent/AU5685296A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/605—Glucagons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
AU56852/96A 1995-05-17 1996-05-14 Immunoassay for glucagon like protein 1 (glp-1) in plasma Abandoned AU5685296A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK56295 1995-05-17
DK562/95 1995-05-17
PCT/DK1996/000212 WO1996036883A1 (en) 1995-05-17 1996-05-14 Immunoassay for glucagon like protein 1 (glp-1) in plasma

Publications (1)

Publication Number Publication Date
AU5685296A true AU5685296A (en) 1996-11-29

Family

ID=8094948

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56852/96A Abandoned AU5685296A (en) 1995-05-17 1996-05-14 Immunoassay for glucagon like protein 1 (glp-1) in plasma

Country Status (2)

Country Link
AU (1) AU5685296A (en)
WO (1) WO1996036883A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005231359A1 (en) * 2004-03-31 2005-10-20 Centocor, Inc. Human GLP-1 mimetibodies, compositions, methods and uses
AU2012207068A1 (en) * 2011-01-21 2013-09-12 Ir2Dx, Inc. Biomarkers for rapid determination of drug efficacy
CN104267194B (en) * 2014-09-23 2016-01-13 上海市东方医院 Human glucagon-like-peptide-1, antibody and kit thereof
MA55504A (en) 2019-04-01 2022-02-09 Novo Nordisk As ANTIBODIES AGAINST LIRAGLUTIDE AND THEIR USE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE164852T1 (en) * 1990-01-24 1998-04-15 Douglas I Buckley GLP-1 ANALOGUE USABLE IN DIABETES TREATMENT

Also Published As

Publication number Publication date
WO1996036883A1 (en) 1996-11-21

Similar Documents

Publication Publication Date Title
AU679244B2 (en) Connecting mechanism for structural members
AU666826B2 (en) Penile elevator
AU6255096A (en) Pegylated modified proteins
AU2380895A (en) Vasoactive intestinal polypeptide
AU5304694A (en) Integrated MTBE process
AU4413096A (en) Phenylalanine free proteins
AU4427296A (en) Novel peptide
AU5635896A (en) Recombinant endotoxin-neutralizing proteins
AU1339595A (en) Phospholipid transfer proteins
AU5685296A (en) Immunoassay for glucagon like protein 1 (glp-1) in plasma
AU7520396A (en) Abl-interactor protein
AU6698496A (en) Metal-containing ribonucleotide polypeptides
AU5284296A (en) Immune-evading proteins
AU6428694A (en) Multiply-coated particles
AU1177895A (en) Forms separating conveyance
AU6890696A (en) Peptide derivatives
AU1117597A (en) Huntingtin-associated protein
AU7997794A (en) Improvements in connecting means
AUPN298695A0 (en) Improvements in fluorescent materials
AU6890596A (en) Peptide derivatives
AU6407994A (en) Recycling processes using fly ash
AU646628B3 (en) Improvements in birdproofing
AU6153396A (en) E6ap-binding proteins
AU8003894A (en) Antigen peptide compound and immunoassay method
AU7070994A (en) Immunoassay